Evidence map›Paper›PMID 40888063›Full record

ArticleInternational journal of cosmetic science2025

Characterization of LED-based hybrid diffuse reflectance spectroscopy method for determination of SPF and UVA-PF in blinded multi-centre study (ALT-SPF).

Carina Reble, Michael Bayer, Bertrand Colson, Tanja Emmler, Jean-Claude Hubaud, Matthias Seise, Eva Perroux-David, Georg Wiora, Daniela F Zamudio Diaz, ALT‐SPF Consortium and 2 more

Abstract readMulticenter Study
In one paragraph

Article in International journal of cosmetic science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carina RebleCourage + Khazaka electronic GmbH, Cologne, Germany.ORCID https://orcid.org/0009-0001-0584-1349
Michael BayerDermatest GmbH, Muenster, Germany.
Bertrand ColsonQuoData GmbH, Dresden, Germany.ORCID https://orcid.org/0000-0003-4743-1150
Tanja EmmlerDermatest GmbH, Muenster, Germany.
Jean-Claude HubaudHelioscience, Marseille, France.
Matthias SeiseSGS Proderm GmbH, Schenefeld/Hamburg, Germany.
Eva Perroux-DavidHelioscience, Marseille, France.
Georg WioraCourage + Khazaka electronic GmbH, Cologne, Germany.
Daniela F Zamudio DiazCharité - Universitätsmedizin Berlin, Department of Dermatology, Venerology and Allergology, Berlin, Germany.ORCID https://orcid.org/0000-0002-0207-1246
ALT‐SPF Consortium
Martina C MeinkeCharité - Universitätsmedizin Berlin, Department of Dermatology, Venerology and Allergology, Berlin, Germany.ORCID https://orcid.org/0000-0002-3937-9906
Stephan BielfeldtSGS Proderm GmbH, Schenefeld/Hamburg, Germany.ORCID https://orcid.org/0000-0002-3230-8558

Funding

ALT-SPF consortiumBundesministerium für Bildung und Forschung FKZ 03ZZ0131DCourage + Khazaka electronic GmbH
6 · The paper itself

Abstract

objectiveThe consortium ALT-SPF performed an international round robin test to characterize non-invasive methods as alternatives to the erythema-based testing of sun protection factor (SPF) according to ISO 24444:2019.

methodsHybrid diffuse reflectance spectroscopy (HDRS) based on a multi-lambda LED light source uses in vivo reflectance spectra on skin to determine sunscreens in vivo absorbance spectra, which are fused with respective in vitro absorbance spectra measured as thin films transmission as described in ISO 24443:2019. As a part of the ALT-SPF consortium initiative, a blinded study on 64 samples was performed in four European laboratories. After further improvements of the method, a blinded re-evaluation based on 16 samples was performed. Five statistical acceptance criteria for new methods were assessed by an independent statistical institute to compare the obtained results to the reference methods for SPF and UVA-PF.

resultsThe initial ALT-SPF study 1 showed that the bias criterion was acceptable, while the reproducibility and interlaboratory variability needed further improvement. The re-evaluation study 2 showed that the reproducibility and interlaboratory variability could be considerably improved. Using only n = 10 volunteers and a bias correction based on the initial ALT-SPF study 1 data, the SPF results of the re-evaluation study 2 were close to the acceptance criteria of the ALT-SPF study with criterion 1 (reproducibility) and only 11% over the limit defined by the performance of the gold standard. The UVA-PF results were within the acceptance limits for the acceptance criteria, except criterion 3 being in the 'almost met' range. The re-evaluation study indicates that the method has a comparable precision to the gold standard methods ISO 24444 and ISO 24443.

conclusionThis study showed that the LED-HDRS method is capable of providing reasonable non-invasive SPF and UVA-PF results and that the performance shows close alignment to the reference method. Thus, it can be proposed as an alternative method to the current standards ISO 24444 and ISO 24443.

Indexed as

Spectrum AnalysisSun Protection FactorSunscreening AgentsUltraviolet RaysFemaleHumansMaleReproducibility of ResultsSunscreening Agentsclaim substantiationemulsionsspectroscopystatisticssun protection factorultraviolet‐A protection factor

Identifiers

PMID40888063
PMCPMC12400023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.